LYONS GARY A 4
4 · NEUROCRINE BIOSCIENCES INC · Filed May 22, 2025
Insider Transaction Report
Form 4
LYONS GARY A
Director
Transactions
- Award
Non-Qualified Stock Option
2025-05-21+3,305→ 3,305 totalExercise: $120.56Exp: 2035-05-21→ Common Stock (3,305 underlying) - Exercise/Conversion
Common Stock
2025-05-22+1,435→ 120,482 total - Exercise/Conversion
Restricted Stock Unit
2025-05-22−1,435→ 0 totalExercise: $0.00→ Common Stock (1,435 underlying) - Award
Restricted Stock Unit
2025-05-21+1,659→ 1,659 totalExercise: $0.00→ Common Stock (1,659 underlying)
Footnotes (5)
- [F1]114,499 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power
- [F2]Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
- [F3]The RSUs will vest in full on May 21, 2026.
- [F4]Option vests in 12 monthly installments beginning June 21, 2025.
- [F5]This RSU award was granted to the Reporting Person on May 22, 2024 and is fully vested.